Antimicrobial Resistance Research Society of India (AMRRSI), a multidisciplinary national initiative dedicated to advancing research, knowledge exchange, and policy dialogue in the field of antimicrobial resistance (AMR), was formally launched during its Inaugural Conclave on 28th March 2026 at Chanakya University, Bengaluru, as part of the Superbug Summit 2026 (26–28 March 2026).
AMRRSI brings together academicians, clinicians, microbiologists, industry leaders, public health experts, and policymakers to collaboratively address one of the most pressing global health challenges of our time — antimicrobial resistance.
The mission is to promote high-quality research in AMR; foster interdisciplinary collaborations; encourage innovation in diagnostics, therapeutics, and surveillance; support evidence-based policymaking; and strengthen capacity building and knowledge dissemination across India.
The launch symbolises a united national effort to strengthen collaboration, accelerate innovation, and build sustainable solutions to combat AMR.
"This is more than just the beginning of an organisation—it marks a moment where we come together to rewrite the narrative of antimicrobial resistance. What started as a vision two years ago, through discussions, persistence, and collaboration, has now taken shape as a national platform dedicated to tackling one of the most pressing global health challenges", said Dr Saravanan Matheshwaran, Associate Professor at the Department of Biological Sciences and Bioengineering, IIT Kanpur, and Vice President, AMRRSI.
